Long-term exposure to a group of synthetic chemicals known as PFAS may hinder the development of bone strength in children, according to a longitudinal study published in the Journal of the Endocrine Society. Researchers found that cumulative PFAS exposure linked to reduced bone density in 12-year-olds, specifically affecting the cortical bone of the distal radius, or the wrist area.
The findings suggest that these “forever chemicals”—per- and polyfluoroalkyl substances—which are pervasive in consumer products and the environment, may interfere with bone mineralization during critical growth windows. Because childhood is a primary period for building peak bone mass, any disruption in density could potentially increase the risk of fractures or osteoporosis later in life.
The study analyzed data from the Health Outcomes and Measures of the Environment (HOME) study, a project led by investigators from the University of North Carolina at Chapel Hill and the George Washington University Milken Institute School of Public Health. By tracking 218 infants from birth through age 12, the team was able to observe how chemical concentrations in the blood correlated with skeletal health over a decade.
The Persistent Impact of PFOA and PFOS
Researchers focused on four specific PFAS compounds: perfluorooctanoic acid (PFOA), perfluorooctane sulfonic acid (PFOS), perfluorohexane sulfonic acid (PFHxS), and perfluorononanoic acid (PFNA). Whereas all four were present in the participants, PFOA emerged as a particularly consistent factor in reduced bone mineral density (BMD).
The team identified an inverse relationship between bone density in the lower 1/3 distal radius and PFOA concentrations at nearly every stage of the children’s development. Specifically, higher PFOA levels were associated with lower BMD Z-scores at birth (via cord blood), as well as at ages 3, 8, and 12. PFOS concentrations also showed a significant link to lower bone density, though this association became more prominent in the later stages of childhood, specifically at ages 8, and 12.
In a cumulative mixture analysis, the researchers determined that the most significant contributors to reduced bone density were PFOS levels at age 12, PFOA levels at age 8, and PFOA exposure at the time of delivery.
Gender-Specific Vulnerabilities
The data revealed that the impact of these chemicals is not uniform across all children. When the researchers stratified the results by gender, they found that the effect of PFOA exposure on wrist bone density varied by age. The association was strongest in boys at age 3 and strongest in girls by the time they reached age 12.
These differences suggest that hormonal shifts during early childhood and the onset of puberty may interact with PFAS compounds, potentially altering how these chemicals disrupt bone mineralization in boys and girls at different developmental milestones.
Complex Interactions in Bone Mineralization
While the primary finding highlighted a reduction in density, the study also uncovered a more complex relationship between certain PFAS and different skeletal sites. Interestingly, higher levels of PFOS and PFHxS at age 3 were positively related to BMD in the total hip, femoral neck, and whole body by age 12.
This divergence indicates that PFAS do not affect the skeleton in a monolithic way. The impact depends heavily on the specific chemical, the timing of the exposure, the sex of the child, and the type of bone being measured. The distal radius is predominantly cortical bone—the hard, dense outer shell of the bone—whereas the hip and femoral neck involve different structural compositions. This suggests that PFAS may specifically target the mineralization process of cortical bone.
| PFAS Compound | Exposure Timing | Effect on Distal Radius BMD | Key Observation |
|---|---|---|---|
| PFOA | Birth, 3, 8, 12 yrs | Inverse (Decrease) | Most consistent negative correlation across all ages. |
| PFOS | 8 and 12 yrs | Inverse (Decrease) | Significant impact in later childhood. |
| PFOS/PFHxS | 3 yrs | Positive (Increase) | Linked to higher BMD in hip and whole body at age 12. |
Why This Matters for Public Health
PFAS are widely used in non-stick cookware, water-repellent clothing, and firefighting foams. Because they do not break down easily in the environment or the human body, they accumulate over time. The U.S. Environmental Protection Agency (EPA) has increasingly flagged these substances for their potential to disrupt the endocrine system and affect metabolic health.
From a clinical perspective, the distal radius is often used as a benchmark for bone health because it is highly sensitive to metabolic changes. A reduction in BMD Z-scores—which compare a child’s bone density to the average for their age and sex—indicates that the bone is not mineralizing at the expected rate. If this trend continues into adolescence, it could lower the “peak bone mass” a person achieves, leaving them more susceptible to fractures in adulthood.
The researchers noted some limitations to the study, most notably the lack of longer-term follow-up beyond age 12. It remains unclear whether these children will experience clinical bone fragility or if the body can compensate for these deficits during the late teenage growth spurts.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Please consult a healthcare provider for concerns regarding pediatric health or environmental exposures.
As regulatory bodies continue to lower the “safe” thresholds for PFAS in drinking water and consumer goods, the next critical step for researchers will be determining whether reducing exposure in early childhood can reverse or halt these skeletal changes. Further longitudinal studies are expected to track these cohorts into their late teens to spot if the BMD deficits persist into adulthood.
Do you have questions about environmental health or PFAS exposure? Share your thoughts in the comments or share this article with other parents and caregivers.
